Liver biomarkers, lipid metabolites, and risk of gestational diabetes mellitus in a prospective study among Chinese pregnant women
Hepatic steatosis index; 肝脂肪变性指数 Liver enzyme; 肝酶; Gestational diabetes mellitus; 妊娠糖尿病; Lipidomics; 脂质组学; Birth cohor; 出生队列;脂质组学 LabEX支持文献- BMC Med
- 11.15
- 17;21(1):150
- human
- MSD
- serum
- 免疫/内分泌
- 糖尿病
Abstract
Abstract
Background: Liver plays an important role in maintaining glucose homeostasis. We aimed to examine the associations of liver enzymes and hepatic steatosis index (HSI, a reliable biomarker for non-alcoholic fatty liver disease) in early pregnancy with subsequent GDM risk, as well as the potential mediation effects of lipid metabolites on the association between HSI and GDM.
Methods: In a birth cohort, liver enzymes were measured in early pregnancy (6-15 gestational weeks, mean 10) among 6,860 Chinese women. Multivariable logistic regression was performed to examine the association between liver biomarkers and risk of GDM. Pearson partial correlation and least absolute shrinkage and selection operator (LASSO) regression were conducted to identify lipid metabolites that were significantly associated with HSI in a subset of 948 women. Mediation analyses were performed to estimate the mediating roles of lipid metabolites on the association of HSI with GDM.
Results: Liver enzymes and HSI were associated with higher risks of GDM after adjustment for potential confounders, with ORs ranging from 1.42 to 2.24 for extreme-quartile comparisons (false discovery rate-adjusted P-trend ≤0.005). On the natural log scale, each SD increment of alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, alkaline phosphatase, and HSI was associated with a 1.15-fold (95% CI: 1.05, 1.26), 1.10-fold (1.01, 1.20), 1.21-fold (1.10, 1.32), 1.15-fold (1.04, 1.27), and 1.33-fold (1.18, 1.51) increased risk of GDM, respectively. Pearson partial correlation and LASSO regression identified 15 specific lipid metabolites in relation to HSI. Up to 52.6% of the association between HSI and GDM risk was attributed to the indirect effect of the HSI-related lipid score composed of lipid metabolites predominantly from phospholipids (e.g., lysophosphatidylcholine and ceramides) and triacylglycerol.
Conclusions: Elevated liver enzymes and HSI in early pregnancy, even within a normal range, were associated with higher risks of GDM among Chinese pregnant women. The association of HSI with GDM was largely mediated by altered lipid metabolism.
LabEx MSD平台助力妊娠糖尿病(GDM)研究
本周为大家带来的文献为发表于BMC Med. (IF:9.3)上的《Liver biomarkers, lipid metabolites, and risk of gestational diabetes mellitus in a prospective study among Chinese pregnant women》。本文使用了LabEx提供的MSD检测服务。
本研究旨在探讨早期孕期肝脏酶和肝脏脂肪指数(HSI)与妊娠糖尿病(GDM)风险之间的关系,并评估脂质代谢产物在这种关联中的潜在中介作用。研究结果表明,即使在正常范围内,早期孕期的肝脏酶和HSI水平升高也与中国孕妇的GDM风险增加有关。具体来说,每种肝脏酶和HSI的标准差增加与GDM风险的增加显著相关。此外,研究发现与HSI相关的15种特定脂质代谢产物,其中主要包括磷脂类(如溶血磷脂酰胆碱和神经酰胺)和甘油三酯。这些脂质代谢产物组成的HSI相关脂质评分表明,HSI与GDM风险之间的关联有多达52.6%可以通过这些脂质代谢产物的间接效应来解释。总之,这项研究表明,早期孕期肝脏酶和HSI的升高与GDM风险增加有关,而这种关联在很大程度上是由脂质代谢的改变所介导的。
LabEx提供的MSD检测服务:
研究者通过MSD检测空腹胰岛素和C 肽。斯皮尔曼偏相关分析包括 974 名有 CRP、空腹胰岛素和 HOMA-IR 数据的参与者。在未患 GDM 的参与者中,ALT、GGT、ALP 和 HSI 与代谢紊乱(如收缩压、空腹胰岛素、C 肽、HOMA-IR、CRP 和临床血脂生物标志物)普遍相关,但与 AST 无关。在患有 GDM 的参与者中,GGT、ALP 和 HSI 通常与这些不利的代谢指标相关。
肝脏生物标志物与代谢特征之间的斯皮尔曼偏相关性。
重要发现:
- 早期妊娠时,即使在正常范围内,肝酶(ALT、AST、GGT和ALP)升高与妊娠糖尿病(GDM)风险增加相关。
- 脂质代谢产物与肝脏脂肪堆积指数(HSI)独立相关,可能介导了HSI与GDM之间的关联。
- HSI是识别GDM高风险孕妇的潜在替代方法。
- 早期妊娠时的肝功能检查可能有助于早期发现和干预GDM。
本网站销售的所有产品及服务均不得用于人类或动物之临床诊断或治疗,仅可用于工业或者科研等非医疗目的。